Notice Regarding the Recording of a Gain on Sale of Investment Securities as Extraordinary Income | REGAL CORPORATION (7938) timely disclosure

Worth reading

54Recurring

Scored from 4 of 5 sections

Direction

Improvement

Direction inferred from the company’s description.

Scale

551

¥ million

Wording

Conditional

How definitive the wording is.

Recognition of Gain on Sale of Investment Securities (Extraordinary Income)

Subject Entity

REGAL CORPORATION

Target Locations / Products

Part of the listed securities held by the Company

Occurrence9 February 2026–31 March 2026 (based on trade execution dates)

This disclosure04/01/2026

Cause

The sale was carried out in accordance with the policy of reducing strategically held shares, with the proceeds to be allocated to expenses arising from the structural reforms.

Amount of Impact on Business Performance

¥551 million (extraordinary income)

Accounting period in which recognized

Consolidated financial results for the fiscal year ending March 2026

Impact on Earnings Forecast

Already incorporated into the earnings forecasts for the consolidated financial results for the fiscal year ending March 2026

Outlook

The gain is expected to be recorded as extraordinary income in the consolidated financial results for the fiscal year ending March 2026

Event that occurred
Item	Details
Event name	Recognition of Gain on Sale of Investment Securities (Extraordinary Income)
Date of occurrence	9 February 2026–31 March 2026 (based on trade execution dates)
Subject Entity	REGAL CORPORATION
Target Locations / Products	Part of the listed securities held by the Company
Cause	The sale was carried out in accordance with the policy of reducing strategically held shares, with the proceeds to be allocated to expenses arising from the structural reforms.
Amount of Impact on Business Performance	¥551 million (extraordinary income)
Accounting period in which recognized	Consolidated financial results for the fiscal year ending March 2026
Impact on Earnings Forecast	Already incorporated into the earnings forecasts for the consolidated financial results for the fiscal year ending March 2026
Outlook	The gain is expected to be recorded as extraordinary income in the consolidated financial results for the fiscal year ending March 2026

Items this document does not state (16)

Date recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The sale was carried out in accordance with the policy of reducing strategically held shares, with the proceeds to be allocated to expenses arising from the structural reforms.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.